Only approved for patients >12 years old and >40kg in weight, no current safety data exists for pregnancy and breastfeeding. More expensive but one time dosing. Genentech, its creator, states a recent phase III trial has shown it to be effective for prophylaxis but not currently FDA indicated for this.
Baloxavir marboxil
Ritonavir-boosted nirmatrelvir
Ritonavir
Emtricitabine/tenofovir
Abacavir/lamivudine
Lopinavir
Remdesivir
Foscarnet